Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs

GLP-1 medications in North Dakota (2026)

Coverage, telehealth, compounding, and platform availability

Reviewed by the glpzoom Editorial Team against primary clinical sources — FDA labeling, peer-reviewed trials, and specialty-society guidelines.
Content current as of June 2026; updated when guidance or availability changes.
Last verified by glpzoom Editorial Team against primary sources

North Dakota Medicaid and insurance coverage

North Dakota Medicaid coverage for GLP-1 weight-loss medications varies by plan and indication. Diabetes coverage is generally available with prior authorization; weight-loss-only coverage is more restrictive. Confirm via your specific plan's formulary or member services.

Commercial insurance coverage of GLP-1s in North Dakota typically requires prior authorization. Most plans cover Ozempic and Mounjaro for documented type 2 diabetes (the easier coverage path). Wegovy and Zepbound for weight loss require BMI documentation, often ≥30 with comorbidity. Use our insurance coverage tool to check your specific plan.

Telehealth prescribing in North Dakota

North Dakota permits interstate telehealth prescribing with state-licensed clinicians. Most major US telehealth platforms operate in North Dakota.

Top US telehealth platforms with active North Dakota availability: Ro Body, Hims Weight Loss, Sequence (Weight Watchers). Each handles insurance and prescribing differently — see our platform comparisons for details on which fits North Dakota patients best.

Compounding pharmacy status (2026)

North Dakota Board of Pharmacy is following FDA April 2026 enforcement guidance restricting large-scale compounded semaglutide. Individualized 503A compounding for documented clinical need may still be permitted.

The national context: FDA proposed permanently ending 503B bulk compounding of semaglutide and tirzepatide on April 30, 2026, with a public comment period through June 29. Most state pharmacy boards are aligning enforcement. Patients currently on compounded GLP-1s in North Dakota should plan transition to branded direct-pay or insurance-covered options. See our guide on the compounding shutdown.

GLP-1 in North Dakota — frequently asked

Does North Dakota Medicaid cover Wegovy or Zepbound for weight loss?+

Varies by plan. North Dakota Medicaid coverage for GLP-1 weight-loss medications varies by plan and indication. Diabetes coverage is generally available with prior authorization; weight-loss-only coverage is more restrictive. Confirm via your specific plan's formulary or member services. Confirm coverage with your specific plan's formulary before assuming approval. For commercial insurance in North Dakota, coverage typically requires prior authorization with BMI documentation.

Can I get Wegovy or Ozempic via telehealth in North Dakota?+

Permitted. North Dakota permits interstate telehealth prescribing with state-licensed clinicians. Most major US telehealth platforms operate in North Dakota. Most major US telehealth platforms — including Ro Body, Hims Weight Loss, Sequence (Weight Watchers) — operate in North Dakota with state-licensed clinicians.

Is compounded semaglutide still legal in North Dakota?+

Winding down. North Dakota Board of Pharmacy is following FDA April 2026 enforcement guidance restricting large-scale compounded semaglutide. Individualized 503A compounding for documented clinical need may still be permitted. The FDA proposed permanently ending 503B bulk compounding of semaglutide and tirzepatide on April 30, 2026. State boards of pharmacy implement enforcement at varying paces.

Which telehealth platforms operate in North Dakota?+

Major platforms with broad North Dakota availability include Ro Body, Hims Weight Loss, Sequence (Weight Watchers). Coverage by program varies — some prescribe branded Wegovy and Zepbound only, others bundle telehealth with compounded preparations where still permitted.

What's the cheapest way to get Wegovy in North Dakota?+

Three main paths: (1) insurance with prior authorization if your plan covers Wegovy (likely $0-$25 copay), (2) NovoCare manufacturer self-pay at $499/month for eligible cash patients, (3) telehealth programs that may bundle branded Wegovy with clinical visits. Direct-to-consumer manufacturer programs typically beat retail pharmacy prices.

Related

We may earn a commission when you click links to partners. Affiliate disclosure.